About

Former journalist intern. Melanie has studied in Germany and Denmark and did an internship at Novo Nordisk, where she had a glimpse to the workings of pharma. She is now a Ph.D. student at the IMP in Vienna.

Articles by Melanie De Almeida

Swedish Oncology Biotech Teams up with World Leading Cancer Center

France’s 2nd Biggest Pharma Enters New Partnership for Immunotherapies

A Potential First Treatment for a Rare Genetic Disease clears Phase I

Will BMS Take Over a Danish Biotech in a Massive €400M Deal?

More News! 20 Mar 2017

UPDATE: Swiss Medtech cancels IPO and goes for Record €411M Exit

French Biotech fails Second Phase II Trial for Cardiovascular Disease

ADVERTISEMENT

Researchers Develop New Virus to Selectively Attack Tumor Cells

UK Immunotherapy Biotech raises Massive Funding in Series C

The First 3D Structure of Active DNA could advance Stem Cell Therapies

New Cardiac Stem Cell Therapy passes Phase I/II Trials

More News! 9 Mar 2017

There’s a New Target for Anti-Aging Therapies

Which European Blockbusters Topped the Charts in 2016?

ADVERTISEMENT